A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Asthma
Interventions
DRUG

lebrikizumab

Given SC on Days 1, 29, and 57

DRUG

montelukast [Singulair]

10 mg given orally once daily for 12 weeks

OTHER

placebo

SC injection given on Days 1, 29, and 57

Trial Locations (112)

1000

Sofia

1010

Auckland

1431

Sofia

1818

Soweto

2113

Johannesburg

5000

Veliko Tarnovo

5300

Gabrovo

7002

Rousse

7130

Cape Town

7200

Razgrad

7505

Parow

7530

Cape Town

7700

Cape Town

8024

Beckenham

9019

Varna

10459

The Bronx

14618

Rochester

22030

Fairfax

23233

Henrico

27262

High Point

28739

Hendersonville

29651

Greer

30096

Duluth

31904

Columbus

32789

Winter Park

33024

Cooper City

34653

New Port Richey

34741

Kissimmee

35209

Birmingham

37701

Jindřichův Hradec

38601

Strakonice

40223

Louisville

46123

Avon

46601

Jablonec nad Nisou

53228

Greenfield

55402

Minneapolis

55441

Plymouth

60305

River Forest

60453

Oak Lawn

61761

Normal

63141

St Louis

68046

Papillion

73120

Oklahoma City

75069

McKinney

75231

Dallas

76712

Waco

77034

Houston

77338

Humble

77375

Tomball

78006

Boerne

78207

San Antonio

78249

San Antonio

78251

San Antonio

80206

Denver

80907

Colorado Springs

85251

Scottsdale

86001

Flagstaff

90025

Los Angeles

90048

Los Angeles

91786

Upland

91801

Alhambra

92270

Rancho Mirage

92801

Anaheim

94063

Redwood City

94558

Napa

95207

Stockton

97202

Portland

97504

Medford

119991

Moscow

190068

Saint Petersburg

193231

Saint Petersburg

194295

Saint Petersburg

194354

Saint Petersburg

197089

Saint Petersburg

197706

Saint Petersburg

300310

Timișoara

390011

Ryazan

400371

Cluj-Napoca

410053

Saratov

410176

Oradea

620109

Yekaterinburg

700115

Iași

06708

Waterbury

07712

Ocean City

22271-100

Rio de Janeiro

90020-090

Porto Alegre

88040-970

Florianópolis

09060-650

Santo André

09080-000

Santo André

L6T 0G1

Brampton

M9V 4B4

Toronto

360 17

Karlovy Vary - Stará Role

0119

Tbilisi

0626

Auckland

15-276

Bialystok

31-023

Krakow

31-159

Krakow

90-153

Lodz

20-089

Lublin

60-693

Poznan

60-823

Poznan

33-100

Tarnów

53-201

Wroclaw

54-239

Wroclaw

00725

Caguas

00909-1711

San Juan

00918

San Juan

030303

Bucharest

052 01

Spišská Nová Ves

0157

Lyttleton

0087

Pretoria Gauteng Province

M23 9QZ

Manchester

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02104674 - A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma | Biotech Hunter | Biotech Hunter